248 related articles for article (PubMed ID: 12029633)
1. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.
Yasui K; Arii S; Zhao C; Imoto I; Ueda M; Nagai H; Emi M; Inazawa J
Hepatology; 2002 Jun; 35(6):1476-84. PubMed ID: 12029633
[TBL] [Abstract][Full Text] [Related]
2. Association of over-expressed TFDP1 with progression of hepatocellular carcinomas.
Yasui K; Okamoto H; Arii S; Inazawa J
J Hum Genet; 2003; 48(12):609-613. PubMed ID: 14618416
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.
Melchor L; Saucedo-Cuevas LP; Muñoz-Repeto I; Rodríguez-Pinilla SM; Honrado E; Campoverde A; Palacios J; Nathanson KL; García MJ; Benítez J
Breast Cancer Res; 2009; 11(6):R86. PubMed ID: 19995430
[TBL] [Abstract][Full Text] [Related]
4. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon.
Shinomiya T; Mori T; Ariyama Y; Sakabe T; Fukuda Y; Murakami Y; Nakamura Y; Inazawa J
Genes Chromosomes Cancer; 1999 Apr; 24(4):337-44. PubMed ID: 10092132
[TBL] [Abstract][Full Text] [Related]
5. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma.
Inagaki Y; Yasui K; Endo M; Nakajima T; Zen K; Tsuji K; Minami M; Tanaka S; Taniwaki M; Itoh Y; Arii S; Okanoue T
Cancer Genet Cytogenet; 2008 Jan; 180(1):30-6. PubMed ID: 18068530
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.
Sakai M; Hibi K; Kanazumi N; Nomoto S; Inoue S; Takeda S; Nakao A
Hepatogastroenterology; 2005; 52(66):1854-7. PubMed ID: 16334792
[TBL] [Abstract][Full Text] [Related]
7. Infrequent amplification of JUN in hepatocellular carcinoma.
Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
[TBL] [Abstract][Full Text] [Related]
8. Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma.
Liu TT; You HL; Weng SW; Wei YC; Eng HL; Huang WT
PLoS One; 2015; 10(12):e0145388. PubMed ID: 26684807
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.
Nishida N; Fukuda Y; Komeda T; Kita R; Sando T; Furukawa M; Amenomori M; Shibagaki I; Nakao K; Ikenaga M
Cancer Res; 1994 Jun; 54(12):3107-10. PubMed ID: 8205525
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.
Ohashi R; Gao C; Miyazaki M; Hamazaki K; Tsuji T; Inoue Y; Uemura T; Hirai R; Shimizu N; Namba M
Anticancer Res; 2001; 21(1B):657-62. PubMed ID: 11299822
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34.
Abba MC; Fabris VT; Hu Y; Kittrell FS; Cai WW; Donehower LA; Sahin A; Medina D; Aldaz CM
Cancer Res; 2007 May; 67(9):4104-12. PubMed ID: 17483321
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
13. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
14. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
[TBL] [Abstract][Full Text] [Related]
15. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
Chen RN; Huang YH; Yeh CT; Liao CH; Lin KH
Cancer Res; 2008 Mar; 68(6):1697-706. PubMed ID: 18339849
[TBL] [Abstract][Full Text] [Related]
16. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
[TBL] [Abstract][Full Text] [Related]
17. [Comparative genomic classification of human hepatocellular carcinoma].
Kaposi-Novák P
Magy Onkol; 2009 Mar; 53(1):61-7. PubMed ID: 19318328
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
19. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
20. Disturbance of circadian gene expression in hepatocellular carcinoma.
Lin YM; Chang JH; Yeh KT; Yang MY; Liu TC; Lin SF; Su WW; Chang JG
Mol Carcinog; 2008 Dec; 47(12):925-33. PubMed ID: 18444243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
